Graphite Bio (GRPH) Stock Highlights

22.26 | +0%

2024-12-21 06:25:02

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the companys long-lived assets are based in the United States.

Statistics

Range Today

22.26 22.26

Volume Today 0

Range 1 Year

2.01 29.82

Volume 1 Year 32.49M

Range 3 Year

1.59 34

Volume 3 Year 185.36M

Range 10 Year

1.59 34

Volume 10 Year 185.36M

Highlights

Market Capitalization 185.19M (small)

Floating Shares 2.38M

Current Price 22.26

Price To Earnings -0.21

Price To Book 0.14

Earnings Per Share -15.33

Payout Ratio 0%

Performance

Latest 0%

1 Month +6%

3 Months +843.22%

6 Months +835.29%

1 Year +843.22%

3 Years +0.72%

5 Years +0.72%

10 Years +0.72%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.